Alleima (ALLEI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
28 Dec, 2025Executive summary
Achieved solid financial performance in Q1 2025, with organic revenue growth of 8% and adjusted EBIT margin of 10.5%, supported by broad-based segment growth and strong operational leverage.
Ongoing growth initiatives in less cyclical, higher-margin segments, expanded geographical footprint, and continued focus on sustainability and safety, including over 80% recycled steel usage and CO₂ emissions reduced by 3% year-over-year.
Solid backlog and positive product mix maintained, with strong performance in key segments like Nuclear, Medical, and Oil & Gas.
No significant impact from global trade barriers or tariffs observed in Q1; main risk identified is potential negative impact on global demand and economic environment.
Launched on-site tubing solution for the hydrogen market, supporting over 70 hydrogen refueling station projects in Europe and Canada.
Financial highlights
Revenues reached SEK 5,150 million, up 8% organically year-over-year, with adjusted EBIT of SEK 540 million (margin 10.5%) and adjusted EPS (diluted) of 1.65.
Free operating cash flow was SEK 46 million, down from SEK 159 million year-over-year, mainly due to higher production volumes, inventory build-up, and growth investments.
Net financial items positive at SEK 13 million, mainly due to revaluation of financial instruments and strong cash position.
Net debt stood at SEK -414 million, with net debt/equity at -0.02x and net debt/adjusted EBITDA at -0.14x, indicating a net cash position.
Return on capital employed (ROCE) excluding cash at 11.9%, up from 7.1% last year.
Outlook and guidance
Economic environment remains cautious with increased uncertainty from global trade policy changes and macroeconomic factors.
Backlog remains solid in key segments, with good near-term delivery visibility and product mix expected to remain similar in Q2.
Currency and metal price headwinds expected in Q2, with estimated negative EBIT impact of SEK 130 million and SEK 150 million, respectively.
CapEx guidance for full year maintained at SEK 1.2 billion, with higher spending expected in Q3 and Q4.
Normalized tax rate projected at 23–25% for FY 2025.
Latest events from Alleima
- Flat organic growth, strong cash flow, and improved EBIT amid robust market sentiment.ALLEI
Q2 20243 Feb 2026 - Flat 2025 revenue, strong cash flow, and SEK 2.50 dividend amid FX and market headwinds.ALLEI
Q4 20252 Feb 2026 - Organic revenue up 3%, EBIT margin 7%, with strong nuclear and medical investments.ALLEI
Q3 202419 Jan 2026 - Stable earnings, strong cash, and growth in key segments despite mixed market demand.ALLEI
Q4 20249 Jan 2026 - Profitability held up despite revenue declines and market uncertainty, with resilient margins.ALLEI
Q2 202516 Nov 2025 - Profitable growth, innovation, and sustainability drive expansion in high-value segments.ALLEI
CMD 20258 Nov 2025 - Flat revenues and lower margins amid weak demand, with cost-saving actions and strong backlogs.ALLEI
Q3 202523 Oct 2025